Preventive Vaccinations of Respiratory Infections during Lung Transplantation
https://doi.org/10.31631/2073-3046-2020-19-4-102-108
Abstract
Relevance. Lung transplantation is recognized as a method of treating terminal stages of lung disease when the drug therapy resource has been exhausted. In addition to the lack of material for transplantation, a serious problem of lung transplantation is the low graft survival rate. The main reasons are infections and primary allograft failure. Aims. To consider the current state of the use of vaccine prophylaxis in the integrated management of patients before and after lung transplantation. Conclusions The prevention of respiratory infections in adult candidates for organ transplantation and recipients is recommended and included in many clinical protocols and recommendations, however, they are based mainly on studies performed on healthy individuals, and are poorly supported by the results obtained in the study of individuals who underwent complete internal organ transplantation. Also, the effectiveness of vaccination remains unexplored, taking into account the individual characteristics of the immune system and the state of population immunity in relation to vaccine-preventable infections.
About the Authors
V. B. Polishchuk
I. I. Mechnikov Research Institute of Vaccines and Sera
Russian Federation
Russian Federation
Valentina B. Polishchuk – Cand. Sci. (Med.), Senior Researcher of Laboratory of Vaccine Prevention and Immunotherapy of Allergic Diseases
5a, Malyy Kazenny lane, Moscow, 105064. +7 (916)-564-65-48
K. V. Mashilov
I. I. Mechnikov Research Institute of Vaccines and Sera
Russian Federation
Russian Federation
Kirill V. Mashilov – Cand. Sci. (Med.) Associate Professor, Senior Researcher, Laboratory of Vaccine Prevention and Immunotherapy of Allergic Diseases
5a, Malyy Kazenny lane, Moscow, 105064. +7 (9250-985-14-24
A. A. Ryzhov
I. I. Mechnikov Research Institute of Vaccines and Sera
Russian Federation
Russian Federation
Aleksey A. Ryzhov – Cand. Sci. (Med.), Senior Researcher of Laboratory of Vaccine Prevention and Immunotherapy of Allergic Diseases
5a, Malyy Kazenny lane, Moscow, 105064. +7 (926)-523-12-01
References
1. Eslamy HK, Newman B. Pneumonia in Normal and Immunocompromised Children: An Overview and Update; 49. Radiol Clin N Am; 2011:895–920.
2. Gangappa S, Kokko KE, Carlson LM, et al. Immune responsiveness and protective immunity after transplantation. Transpl Int 2008;21(4):293–303.
3. Danzinger-Isakov L, Kumar D. AST Infectious diseases community of practice, guidelines for vaccination of solid organ transplant candidates and recipients , american journal of transplantation, 2009; т. 9, вып. Suppl 4, С. S258–S262.
4. Rubin LG, Levin MJ, Ljungmanet P, et al. Infectious Diseases Society of America. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2014;58(3): e44–e100.
5. Hosenpud JD, Bennett LE, Keck BM, et al. The Registry of the international society for heart and lung transplantation: fifteenth official report – 1998. J Heart Lung Transplant 1998;17:656–68.
6. 1997 Annual report of the U.S. scientific registry for transplant recipients and the organ procurement and transplantation network – transplant data: 1988–1996. Richmond, Va.: United Network for Organ Sharing, 1997.
7. Remund KF, Best M, Egan JJ. Infections relevant to lung transplantation. Proc Am ThoracSoc. 2009;6(1):94–100.
8. Arcasoy SM, Kotloff RM. Lung transplantation. N Engl J Med 1999;340(14): 1081–1091.
9. Kotloff RM, Ahya VN, Crawford SW. Pulmonary complications of solid organ and hematopoietic stem cell transplantation. Am J RespirCrit Care Med 2004;170(1):22–48.
10. Kramer MR, Marshall SE, Starnes VA, et al. Infectious complications in heart-lung transplantation: analysis in 200 episodes: Arch Intern Med 1993;153:2010–6.
11. Mazzone PJ, Mossad SB, Mawhorteret SD, et al. Cell-mediated immune response to influenza vaccination in lung transplant recipients. J Heart Lung Transplant 2004;23(10):1175–1181.
12. Burguete SR, Maselli DJ, Fernandez JF, et al. Lung transplant infection. Respirology 2013;18(1):22–38.
13. Speich R, van der Bij W. Epidemiology and management of infections after lung transplantation. Clin Infect Dis 2001;33(Suppl. 1):58–65.
14. Kramer MR, Marshall SE, Starnes VA, et al. Infectious complications in heart-lung transplantation: analysis in 200 episodes: Arch Intern Med 1993;153:2010–6.
15. Maurer JR, Tullis DE, Grossman RF, et al. Infectious complications following isolated lung transplantation. Chest 1992;101:1056–9.
16. Flume PA, Egan TM, Paradowski LJ, et al. Infectious complications of lung transplantation: impact of cystic fibrosis. Am J Respir Crit Care Med 1994;149:1601–7.
17. Aver’yanov A.V., Babkin A.P., Bart B.Ya. et al. Ergoferon and Oseltamivir in treatment of influenza: results of multicentre randomized comparative clinical trial.Antibiotiki i himioterapiya. 2012;57(7–8):23–30 (In Russ.).
18. Chuchalin A.G., Bilichenko T.I., Osipova G.L. et al. Vakcinoprofilaktika boleznej organov dyhaniya v ramkah pervichnoj mediko-sanitarnoj pomoshchi naseleniyu. Klinicheskie rekomendacii. Pul’monologiya. 2015;2(25):1–19 (In Russ.).
19. Bogaert D, van der Valk P, Ramdin R, et al. Host-pathogen interaction during pneumococcal infection in patients with chronic obstructive pulmonary disease. Infect Immun 2004;72(2):818–823.
20. Ryzhov AA, Kostinov MP, Magarshak OO. Primenenie vakcin protiv pnevmokokkovoj i gemofil’noj tipa b infekcij u lic s hronicheskoj patologiej.`Epidemiology and Vaccinal Prevention. 2004;6(19):24–27 (In Russ.).
21. Serrano B, Bayas JM, Bruni L, et al. Solid organ transplantation and response to vaccination. Vaccine 2007;25(42):7331–7338.
22. Recommended Adult Immunization Schedule – United States-2016. Доступно на: http://www.cdc. gov/vaccines/schedules/downloads/adult/adult (accessed 22.09.2016).
23. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. Revised 2016. Bethesda: GOLD 2016. Доступно на: http://goldcopd.org/ (accessed 22.09.2016).
24. Kostinov M.P., Pahomov D.V., Magarshak O.O., Suhinin M.V. Prophylaxis of pneumococcal infection with vaccines for prevention of complications and death in patients with influenza. Voprosy sovremennoj pediatrii. 2009;8(6):131–134 (In Russ.).
25. Kumar D, Humar A, Plevneshiet A, et al. Invasive pneumococcal disease in solid organ transplant recipients – 10-year prospective population surveillance. Am J Transplant 2007;7(5):1209–1214.
26. deBruyn G, Whelan TP, Mulliganet MS, et al. Invasive pneumococcal infections in adult lung transplant recipients. Am J Transplant 2004;4(8):1366–1371.
27. Gasink LB, Wurcell AG, Kotloff RM, et al. Low prevalence of prior streptococcus pneumoniae vaccination among potential lung transplant candidates. Chest 2006;130(1):218–221.
28. Eckerle I, Rosenberger KD, Zwahlen M, et al. Serologic Vaccination Response after Solid Organ Transplantation: A Systematic Review. PLoS One 8, вып. 2 (2013 г.):e56974. 31.
29. Cordero E, Roca-Oporto C, Bulnes-Ramos A, et al. Guidelines for Vaccination of Solid Organ Transplant Candidates and Recipients . Clinical Infectious Diseases 64 (2017 г.): 29–38.
30. Vilchez RA, McCurry K. Influenza Virus infection in adult solid organ transplant recipients. American Journal of Transplantation. 2002;2:287–291.
31. Mazzone PJ, Mossad SB, Mawhorter SD, et al. The humoral immune response to influenza vaccination in lung transplant patients. EurRespir J 2001;18(6):971–976.
32. Hayney MS, Welter DL, Francois M, et al. Influenza vaccine antibody responses in lung transplant recipients. Prog Transplant 2004;14(4):346–51.
33. Kostinov M.P., Protasov A.D., Zhestkov A.V., Polishhuk V.B. Perspectives of vaccination with 13-valent pneumococcal vaccine in adults with chronic respiratory diseases. PULMONOLOGIYA. 2014;(4):57–63 (In Russ.). https://doi.org/10.18093/0869-0189-2014-0-4-57–63.
34. Primenenie vakcin Pnevmo 23 i Akt-HIB v komplekse lechebno-profilakticheskih meropriyatij pri hronicheskih vospalitel’nyh zabolevaniyah legkih u detej. Posobie dlya vrachej. M.P. Kostinov, red. M.: MDV 2004, p. 48 (In Russ.).
35. Kostinov MP, Zhestkov AV, Pakhomov DV, et al. Post-vaccination immunity to pneumococcal, Haemophilus influenza type b infection and influenza in patients with chronic obstructive pulmonary disease (COPD). J Vaccines Vaccin 2014; 5: 2.
36. Kumar D, Rotstein C, Miyata G, et al. Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients. J Infect Dis 2003;187(10):1639–1645.
37. Protasov A.D., Zhestkov A.V., Lavrent’eva N.E. i dr. Effect of complex vaccination against pneumococcal, haemophilus type b infections and influenza in patients with chronic obstructive pulmonary disease. Zhurnal mikrobiologii, epidemiologii i immunobiologii; [Journal of Microbiology, Epidemiology and Immunobiology]. 2011;(4):80–84.
38. Linnemann CC Jr., First MR, Schiffman G. Re-vaccination of renal transplant and hemodialysis reci-pients with pneumococcal vaccine. Arch Intern Med 1986;146(8):1554–1556.
39. Kostinov M. P., Chuchalin A. G., Chebykina A. B. Postvakcinal’nyj immunitet k grippu u vpervye i povtorno vakcinirovannyh bol’nyh s bronholegochnoj patologiej. Immunologiya. 2011;6:306–310 (In Russ.).
40. Dransfield MT, Nahm MH, Han MK, et al.; COPD Clinical Research Network. Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease. Am J RespirCrit Care Med 2009;180(6):499–505.
41. Gattringer R, Winkler H, Roedler S, et al. Immunogenicity of a combined schedule of 7‐valent pneumococcal conjugate vaccine followed by a 23‐valent polysaccharide vaccine in adult recipients of heart or lung transplants. Transplant Infectious Dise. 2011 Oct;13, (5):540–44.
42. Chow J, Golan Y. Vaccination of solid-organ transplantation candidates. Clin Infect Dis 2009;49(10):1550–1556.
43. Kostinov M. P. Ot profilakticheskogo k terapevticheskomu `effektu vakcin protiv pnevmokokkovoj i gemofil’noj tipa b infekcij u pacientov s bronholegochnoj patologiej. M.: Medicina, 2007:182 (In Russ.).
44. Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, October 2007–September 2008. Ann Intern Med 2007;147(10):725–729.
45. Sarmiento E., Rodríguez-Hernández C, Rodríguez-Molina J, et al. Impaired anti-pneumococcal polysaccharide antibody production and invasive pneumococcal infection following heart transplantation. IntImmunopharmacol 2006;6(13–14):2027–2030.
46. Vakcinaciya vzroslyh s bronholegochnoj patologiej. Rukovodstvo dlya vrachej. M.P. Kostinov, ed. M.: ArtStudiya Sozvezdie. 2013:112 (In Russ.).
47. Avery RK, Ljungman P. Prophylactic measures in the solid-organ recipients before transplantation. Clin Infect Dis 2001;33(Suppl 1):S15–S21
48. Kostinov M. P., Maleev V.V. Hib-infekciya: voprosy vakcinoprofilaktiki. M.: Medicina dlya vseh, 1998:78 (In Russ.).
49. Kliniko-immunologicheskaya `effektivnost’ immunobiologicheskih preparatov. Spravochnik. M.P. Kostinov, N.A. Ozereckovskij, red. M.: Miklosh, 2004: 256 (In Russ.).
50. Cherdancev A. P., Kostinov M. P., Kusel’man A. I. et al. Izuchenie klinicheskoj bezopasnosti vakcinacii protiv grippa u beremennyh. Medicinskij al’manah. 2011;4(17):120–122 (In Russ.).
51. Novoe v klinike, diagnostike i vakcinoprofilaktike upravlyaemyh infekcij. M.P. Kostinov, ed. M.: Medicina dlya vseh, 1997:110 (In Russ.).
52. Immunokorrekciya v pediatrii. Prakticheskoe rukovodstvo dlya vrachej: M.P. Kostinov, ed. M.: Medicina dlya vseh, 1997:111 (In Russ.).
53. Vakcinaciya protiv gepatita V, grippa i krasnuhi vzroslyh pacientov s hronicheskimi zabolevaniyami. Rukovodstvo. M. P. Kostinov, V. V. Zverev, ed. M.: MDV, 2009:196 (In Russ.).
54. Respiratornaya medicina: rukovodstvo v 3 tomah. A. G. Chuchalin, ed., 2-e izd., pererab. i dop. M. Littera. 2017:554 (In Russ.).
55. Rukovodstvo po klinicheskoj immunologii v respiratornoj medicine (1-e izd.). M. P. Kostinov, A. G. CHuchalin, ed. M.: OOO ATMO, 2016:128 (In Russ.).
56. Vakcinaciya detej s narushennym sostoyaniem zdorov’ya. Prakticheskoe rukovodstvo dlya vrachej. 4-e izd. M.P. Kostinov, red. M.: Medicina dlya vseh. 2013:432 (In Russ.).
57. Rukovodstvo po klinicheskoj immunologii v respiratornoj medicine (2-e izd. dopol.) M. P. Kostinova, A. G. CHuchalina, red M.: Gruppa MDV, 2018:304 (In Russ.).
58. Federal’noe rukovodstvo po ispol’zovaniyu lekarstvennyh sredstv (formulyarnaya sistema, spravochnoe izdanie) Vypusk XVII. Chuchalin A.G., Yasnecov V.V., ed. Glava 19 Vakciny. M.: OOO Vidoks. 2016:745–768 (In Russ.).
Review
For citations:
Polishchuk V.B., Mashilov K.V., Ryzhov A.A. Preventive Vaccinations of Respiratory Infections during Lung Transplantation. Epidemiology and Vaccinal Prevention. 2020;19(4):102-108. (In Russ.) https://doi.org/10.31631/2073-3046-2020-19-4-102-108
Views:
928
Email this article 